US20050187612A1 - Method of recapturing a stent - Google Patents

Method of recapturing a stent Download PDF

Info

Publication number
US20050187612A1
US20050187612A1 US11/109,604 US10960405A US2005187612A1 US 20050187612 A1 US20050187612 A1 US 20050187612A1 US 10960405 A US10960405 A US 10960405A US 2005187612 A1 US2005187612 A1 US 2005187612A1
Authority
US
United States
Prior art keywords
stent
fluid
catheter
lumen
delivering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/109,604
Inventor
Tarun Edwin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bard Peripheral Vascular Inc
Original Assignee
Bard Peripheral Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bard Peripheral Vascular Inc filed Critical Bard Peripheral Vascular Inc
Priority to US11/109,604 priority Critical patent/US20050187612A1/en
Publication of US20050187612A1 publication Critical patent/US20050187612A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0023Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
    • A61F2210/0042Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply using a fluid, e.g. circulating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body

Definitions

  • the present invention relates generally to endoluminal devices, and more particularly to stents.
  • Stents and similar endoluminal devices have been used to expand a constricted vessel to maintain an open passageway through the vessel in many medical situations, for example, following angioplasty of a coronary artery.
  • stents are useful to prevent restenosis of the dilated vessel through proliferation of vascular tissues.
  • Stents can also be used to reinforce collapsing structures in the respiratory system, the reproductive system, biliary ducts or any tubular body lumens. Whereas in vascular applications fatty deposits or “plaque” frequently cause the stenosis, in many other body lumens the narrowing or closing may be caused by malignant tissue.
  • Fluids have traditionally been used to pressurize the angioplasty balloons used to open restricted vessels.
  • the balloons may have a variety of shapes including a coiled form.
  • fluid is injected into the balloon to inflate the device and maintain turgidity.
  • Shturman U.S. Pat. No. 5,181,911 discloses a perfusion balloon catheter wound into a helically coiled shape with one end attached to a fitting and the other to a syringe for inflating the balloon with fluid.
  • the balloon When the balloon is inflated, its coiled form allows blood flow thorough the open center of the structure.
  • it is possible to actually have fluid flow within the balloon structure so that the syringe can deliver fluid into the balloon, fluid can flow through the balloon, and fluid can then exit through a second lumen in a catheter attached to the syringe.
  • Coiled stents that are connected to a catheter apparatus, as in Wang et al. (U.S. Pat. No. 5,795,318), are used for temporary insertion into a patient.
  • Wang et al. discloses a coiled stent of shape-memory thermoplastic tube that can be converted from a relatively narrow diameter to a larger coiled form by heating.
  • the narrow diameter coil is mounted at the end of a catheter over a balloon and in a preferred embodiment a resistive heating element runs down the length of the thermoplastic element.
  • An electric current is applied to heat the element thereby softening it while the balloon is expanded to enlarge the diameter of the coil.
  • the temporary stent has performed its duty, it is again heated and removed while in the softened state.
  • the thermoplastic tube is supplied with an additional lumen so that liquid drugs can flow into the stent and delivered through apertures or semi-permeable regions.
  • the present invention is an endoluminal coil stent comprising a hollow tube formed into a series of loops or other known stent shapes which initially has a low profile and diameter.
  • This structure can be delivered into a patient's vascular system and expanded to full size.
  • the present invention to provides a stent that is hollow allowing the passage of fluid.
  • the stent has either one or a plurality of passageways for fluid flow.
  • the stent is attached to a catheter via a special fitting so that when engaged with the catheter, fluid flows freely from the catheter to the stent with a possible return circuit through the catheter. When disengaged, the fitting prevents leakage from the stent permitting the stent to remain in place in a patient's vasculature.
  • This invention provides a way of treating vascular areas affected with malignant growths or experiencing restenosis from smooth muscle cell proliferation, etc.
  • the stent is inserted in a small diameter configuration and after being enlarged to a larger diameter, acts as a support device for the areas of restenosis or malignant growth.
  • the stent can treat these affected areas in a unique way by flowing radioactive, heated or cryogenic fluids through the stent.
  • the present invention also provides a way of delivering drugs to an affected site.
  • a stent to accomplish this purpose can be composed of several different materials.
  • the stent can formed from a metal or other material with small pores machined or otherwise formed (e.g., with a laser). When such a stent is filed with a drug, that drug slowly disperses through the pores.
  • an entire metal tube or portions of the tube could be formed e.g., from sintered metal powder thereby forming a porous structure for drug delivery.
  • Another embodiment would alternate a metal tube (for structural stability) with dispensing segments inserted at various intervals. The segments would be perforated to allow seepage of the drug or would be otherwise formed from a porous material.
  • Another embodiment employs an expanded polytetrafluoroethylene (PTFE) tube around a support wire or metal tube in the form of a coiled stent so that a hollow passageway is created between the metal and the PTFE. A drug is flowed into this space and slowly dispensed through the porous PTFE.
  • PTFE polytetrafluoroethylene
  • One embodiment of the hollow stent of the present invention comprises a shape memory metal such as nitinol.
  • Shape memory metals are a group of metallic compositions that that have the ability to return to a defined shape or size when subjected to certain thermal or stress conditions. Shape memory metals are generally capable of being deformed at a relatively low temperature and, upon exposure to a relatively higher temperature, return to the defined shape or size they held prior to the deformation. This enables the stent to be inserted into the body in a deformed, smaller state so that it assumes its “remembered” larger shape once it is exposed to a higher temperature (i.e. body temperature or heated fluid) in vivo.
  • a higher temperature i.e. body temperature or heated fluid
  • the hollow stent has an inlet and an outlet so that a complete fluid path can be created, and fluid can be continually circulated through the stent.
  • the inlet and outlet are at opposite ends of the stent.
  • two lumens can be connected at a distal end of the structure so that the outlet and inlet are both together at one end.
  • Other arrangements can be readily envisioned by one of ordinary skill in the art.
  • the stent is inserted into the body while connected to a catheter in a small, deformed state. Once inside the patient's body the stent is advanced to a desired position and expanded to its larger full size. If the stent is composed of shape memory metal, for example, the stent expands from its small-deformed state to its remembered larger state due to the higher body temperature or due to the passage of “hot” fluid through the stent. Subsequently “treatment” fluid (e.g., heated, cryogenic or radioactive) is pumped through the catheter to the stent where it is circulated throughout the stent, treating the adjacent vascular walls. The catheter can either be left in place for a certain period of time or removed, leaving the fluid inside the stent. This would particularly be the case with radioactive fluid or with a porous drug delivery stent.
  • treatment fluid e.g., heated, cryogenic or radioactive
  • the stent can be removed by reattaching the catheter allowing one to chill and shrink the stent (in the case of a memory alloy).
  • the device can readily be used in its tethered form to remove memory alloy stents of the present invention or of prior art design.
  • a device of the present invention is inserted into the vasculature to rest within the stent to be removed. Warm fluid is then circulated causing the stent to expand into contact with the memory alloy stent that is already in position. At this point cryogenic (e.g., low temperature) fluid is circulated causing the attached stent and the contacted stent to shrink so that the combination can be readily withdrawn.
  • FIG. 1 is a perspective view of a hollow coiled stent.
  • FIG. 2 is a perspective view of a valve assembly to be used with FIG. 1 .
  • FIG. 3 is a sectional view of the hollow stent tube of FIG. 2 .
  • FIG. 4 is a representation of the stent of FIG. 1 in the position for treatment.
  • FIG. 5 is a sectional view of a second embodiment of a hollow coiled stent.
  • FIG. 6 is a perspective view of a second embodiment of a hollow coiled stent.
  • FIG. 7 is a perspective view of a third embodiment of a hollow coiled stent.
  • FIG. 8 is a perspective view of a valve assembly to be used with FIG. 6 .
  • FIG. 9 is a perspective view of a fourth embodiment of a hollow coiled stent.
  • FIG. 10 is a sectional view of the hollow stent tube of FIG. 8 .
  • FIG. 11 ( 11 a , 11 b, and 11 c ) is an illustration of the method detailed in FIG. 12 .
  • FIG. 12 is a flow diagram explaining use a stent of the present invention to a shape memory stent already in place.
  • FIG. 1 depicts a preferred embodiment of this invention.
  • a medical apparatus 10 comprising an endoluminal stent 20 attached to a delivery catheter 30 by means of a valve assembly 40 .
  • endoluminal stent 20 is generally coiled in shape leaving a tubular space down the center of its length.
  • the tubing 22 of the stent 20 is preferably composed of a metal material that can be crimped onto a balloon catheter (not shown) for insertion into a body. Once positioned inside of the body at the desired location, the balloon can be inflated, bringing the stent from a compact small size to its enlarged full size thus opening a pathway for blood flow.
  • Pathways 26 and 28 have opposite flowing fluid streams and connect at the distal end 24 of stent 20 .
  • radioactive, heated or cryogenic liquids can continuously flow through stent 20 for the purpose of killing or preventing proliferation of cells.
  • heat or hot is meant temperatures above body temperature.
  • cryogenic or “cold” is meant temperatures below body temperature.
  • the stent 20 can either remain connected to a delivery catheter 30 for temporary insertion, or be detached for a more permanent insertion. In either case, fluid flow can be circulated throughout stent 20 prior to disconnection.
  • fluid passageways connected to the stent 20 are lumens of the delivery catheter so that when the catheter is withdrawn, fluid flow must cease.
  • valve 40 may comprise a simple back flow preventer.
  • a ball 45 which sits in a ball seat 44 is forced back against a spring 46 and the valve 40 opens for the incoming fluid pathway 28 .
  • a similar arrangement allows pressure to open the outgoing fluid pathway 26 .
  • a check ball valve is shown only as an example. Flap valves or any of a number of other back flow valve designs well known in the art can be employed. Complex systems in which a bayonet-type attachment automatically opens a valve are also possible.
  • the catheter 30 comprises a catheter shaft 32 , which further contains two fluid pathways 34 and 36 as seen in FIG. 2 .
  • the valve assembly 40 has small hollow needles 48 that are designed to puncture elastomer diaphragms 25 .
  • the catheter 30 is slightly larger in diameter than the stent member 20 so that the catheter tubing wall 32 forms a friction fit over the stent wall 22 . This creates a seal between the catheter 30 , and the stent 20 for fluid delivery and removal.
  • the back flow preventer 40 could be on the stent 20 and the diaphragms could be on the catheter 30 .
  • stent 20 is inserted into the body to the desired site through the use of a catheter insertion device well known in the art.
  • FIG. 4 depicts stent 20 in its enlarged form after it has been inserted into the body at the affected location and expanded.
  • Other means of stent expansion other than a balloon catheter are possible.
  • the stent 20 is formed from shape memory metal, such as Nitinol, the heat of the body can cause the stent 20 to assume a larger, remembered form. Alternatively, heated fluid can be circulated through the stent to cause it to recover its remembered form.
  • a self-expanding stent made of a spring-type alloy can also be employed. In that case the delivery catheter would be equipped with means (e.g., an outer sheath) to keep the stent compressed until it was at the desired location.
  • the passageway is enlarged to permit increased blood flow.
  • fluids can pass through the interior of tubes 22 of the hollow stent 20 to treat the vascular wall.
  • the walls of the vasculature can be treated by running either a radioactive, cryogenic or heated fluid through the stent 20 or by delivering a drug through a stent equipped for drug diffusion (e.g., through holes or a porous region).
  • FIG. 5 depicts a second embodiment of the invention.
  • the hollow stent 60 has only one fluid pathway 66 , an inlet without an outlet, and is used to deliver drugs to affected areas.
  • drugs are delivered through the catheter to the stent 60 .
  • Stent 60 can be constructed in various ways to facilitate the delivery of drugs. In one case, as shown in FIG. 6 , the stent 60 is constructed with regions or segments that have pores 64 to allow drug seepage from the tubing 62 . Alternatively, continuously porous metal, porous plastic, or a combination of metal and plastic can be used.
  • the perforations 64 or slits in the stent to facilitate drug delivery must be of sufficiently small size to allow the passage of the drug through the entire length of the stent so that all areas can be treated. It will be apparent that pore size can control the rate at which the drug is dispensed. It is possible to cover the pores 64 with semi-permeable membrane to further control and restrict drug outflow. A semi-permeable membrane with inclusion of an osmotic agent with the drug will result in water uptake and more rapid and controlled pressurized delivery of the drug.
  • a third embodiment of the invention has a hollow stent 70 containing a single fluid pathway.
  • the tubing 72 can be made of any of the materials discussed above, but in this embodiment, the stent 70 has an inlet path 78 that carries the fluid to the distal end 74 of stent 70 where it then runs through the coils.
  • a valve 80 connects the stent 70 to catheter 30 .
  • FIG. 8 shows a cross-sectional view of valve 80 . The pressure from the liquid sent through the catheter causes the gate 82 of valve 80 to open to allow the fluid into the inlet path 78 .
  • the pressure that forces the opening of gate 82 causes the simultaneous opening of gate 84 , allowing the fluid that is circulated through the stent 70 to exit through pathway 36 of catheter 30 .
  • the fluid entering and exiting through catheter 30 must also go through a check ball valve assembly similar to the one shown in FIG. 2 . Again, flaps or other “one way” valve mechanisms can be applied. After all incoming fluid has been delivered to the stent 70 , the absence of pressure causes gate 82 and gate 84 to close, thereby closing valve 80 .
  • This design can be used with any of the fluids mentioned above.
  • the stent 70 can be used to circulate radioactive or cryogenic fluids for treatment of the vascular walls and can also be perforated for the delivery of drugs.
  • a hollow coiled stent 90 is formed from polytetrafluoroethylene (PTFE) 92 .
  • PTFE polytetrafluoroethylene
  • FIG. 9 a perspective view of this embodiment can be seen.
  • the stent 90 consists of a support wire 94 over which PTFE 92 is fitted. The pliable structure resulting is then formed into a coiled stent.
  • the PTFE 92 is fitted around the wire 94 so that there is sufficient room to allow the passage of fluid.
  • FIG. 10 shows a cross-sectional view of stent 90 , illustrating the pathway 96 created around the support wire 94 to allow the passage of fluid.
  • stretched expanded PTFE can be used to create a porous stent to facilitate the delivery of drugs.
  • the wire 94 can also be hollow (passageway 95 ) so that the stent 90 can simultaneously deliver drugs and radioactive fluid or temperature regulating fluid.
  • FIG. 11 A fifth embodiment of the invention is illustrated in FIG. 11 and described in a flow diagram shown in FIG. 12 .
  • This embodiment is a method for recapturing an existing shape memory metal stent already in the body.
  • a shape memory metal stent A is inserted into the body in its small, deformed state through the use of an insertion device well known in the art in step 112 .
  • the inserted stent A in its deformed state is placed into the center of a memory alloy stent B that is already in an enlarged support position in the body in step 114 .
  • the deformed stent A is then enlarged so that it comes in contact with stent B. This can be accomplished in one of two ways.
  • Either the stent A may enlarge due to the higher in vivo body temperature in step 115 , or a hot liquid may be pumped through stent A to cause it to expand in step 116 .
  • cryogenic liquid may be pumped through stent A so that both stent A and stent B are chilled and either shrink down to their deformed states or become sufficiently relaxed to allow ready removal in step 118 .
  • stents A and B are easily removed from the body in step 119 by withdrawing the catheter attached to stent A.
  • FIG. 11 a illustrates stent A in its reduced state being inserted into stent A.
  • FIG. 11 b shows an enlarged version of stent A contacting stent B.
  • a temperature change caused, for example, by fluid circulating through stent A will shrink both stents and enable their removal ( FIG. 11 c ).

Abstract

A method to retrieve a deployed stent in a blood vessel. In one embodiment, the method includes the introduction of a retrieval stent within the lumen of the deployed stent, enlarging the retrieval stent to contact a surface of the deployed stent and contracting the retrieval stent which in turn causes the deployed stent to contract for removal from the blood vessel. The retrieval stent may contain one or more fluid passageways through which heated or cooled fluid can circulate and may be connected to a catheter for circulation of the fluid. Fluid flow may be regulated by a valve or valve assembly incorporated in the stent and/or the catheter.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of application Ser. No. 10/638,182, filed Aug. 7, 2003, now U.S. Pat. No. 6,881,220, which is a division of application Ser. No. 09/975,743, filed Oct. 11, 2001, now U.S. Pat. No. 6,623,519, which is a division of application Ser. No. 09/321,496, filed May 27, 1999, now U.S. Pat. No. 6,358,276, which claims the benefit of U.S. Provisional Application No. 60/105,768, filed Sep. 30, 1998. This application expressly incorporates by reference the entirety of each of the above-mentioned applications as if fully set forth herein.
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • Not applicable.
  • REFERENCE TO A COMPACT DISK APPENDIX
  • Not applicable.
  • BACKGROUND OF THE INVENTION
  • The present invention relates generally to endoluminal devices, and more particularly to stents.
  • Stents and similar endoluminal devices have been used to expand a constricted vessel to maintain an open passageway through the vessel in many medical situations, for example, following angioplasty of a coronary artery. In these situations, stents are useful to prevent restenosis of the dilated vessel through proliferation of vascular tissues. Stents can also be used to reinforce collapsing structures in the respiratory system, the reproductive system, biliary ducts or any tubular body lumens. Whereas in vascular applications fatty deposits or “plaque” frequently cause the stenosis, in many other body lumens the narrowing or closing may be caused by malignant tissue.
  • Fluids have traditionally been used to pressurize the angioplasty balloons used to open restricted vessels. The balloons may have a variety of shapes including a coiled form. In such a device fluid is injected into the balloon to inflate the device and maintain turgidity. Shturman (U.S. Pat. No. 5,181,911) discloses a perfusion balloon catheter wound into a helically coiled shape with one end attached to a fitting and the other to a syringe for inflating the balloon with fluid. When the balloon is inflated, its coiled form allows blood flow thorough the open center of the structure. At the same time it is possible to actually have fluid flow within the balloon structure so that the syringe can deliver fluid into the balloon, fluid can flow through the balloon, and fluid can then exit through a second lumen in a catheter attached to the syringe.
  • Coiled stents that are connected to a catheter apparatus, as in Wang et al. (U.S. Pat. No. 5,795,318), are used for temporary insertion into a patient. Wang et al. discloses a coiled stent of shape-memory thermoplastic tube that can be converted from a relatively narrow diameter to a larger coiled form by heating. The narrow diameter coil is mounted at the end of a catheter over a balloon and in a preferred embodiment a resistive heating element runs down the length of the thermoplastic element. An electric current is applied to heat the element thereby softening it while the balloon is expanded to enlarge the diameter of the coil. Upon cooling the enlarged coil hardens and the balloon is withdrawn. After the temporary stent has performed its duty, it is again heated and removed while in the softened state. In one embodiment the thermoplastic tube is supplied with an additional lumen so that liquid drugs can flow into the stent and delivered through apertures or semi-permeable regions.
  • The attempt to kill or prevent proliferation cells is a common theme in clinical practice. This is generally true in vascular and non-vascular lumens. It is known that ionizing radiation can prevent restenosis and malignant growth. Although the effect of temperature extremes, e.g., cryogenic (cold) or hot temperatures, on cellular activity is not as well researched, it may provide a safer approach to control of tissue proliferation. Among the drawbacks of the prior art coiled balloons is that the balloon material is relatively weak so that expansion and contraction cause the balloon to fail. Failure of a balloon containing radioactive or cryogenic fluids could be catastrophic. It would be desirable to provide a catheter based, minimally invasive device for stenting support that could deliver hot or cryogenic or radioactive fluids or drugs and that would be sturdy and could remain in the body for extended periods of time, detached from the insertion device.
  • BRIEF SUMMARY OF THE INVENTION
  • In its simplest embodiment the present invention is an endoluminal coil stent comprising a hollow tube formed into a series of loops or other known stent shapes which initially has a low profile and diameter. This structure can be delivered into a patient's vascular system and expanded to full size. The present invention to provides a stent that is hollow allowing the passage of fluid. The stent has either one or a plurality of passageways for fluid flow. The stent is attached to a catheter via a special fitting so that when engaged with the catheter, fluid flows freely from the catheter to the stent with a possible return circuit through the catheter. When disengaged, the fitting prevents leakage from the stent permitting the stent to remain in place in a patient's vasculature.
  • This invention provides a way of treating vascular areas affected with malignant growths or experiencing restenosis from smooth muscle cell proliferation, etc. The stent is inserted in a small diameter configuration and after being enlarged to a larger diameter, acts as a support device for the areas of restenosis or malignant growth. In addition, the stent can treat these affected areas in a unique way by flowing radioactive, heated or cryogenic fluids through the stent.
  • The present invention also provides a way of delivering drugs to an affected site. A stent to accomplish this purpose can be composed of several different materials. For example, the stent can formed from a metal or other material with small pores machined or otherwise formed (e.g., with a laser). When such a stent is filed with a drug, that drug slowly disperses through the pores. Alternatively, an entire metal tube or portions of the tube could be formed e.g., from sintered metal powder thereby forming a porous structure for drug delivery. Another embodiment would alternate a metal tube (for structural stability) with dispensing segments inserted at various intervals. The segments would be perforated to allow seepage of the drug or would be otherwise formed from a porous material. Another embodiment employs an expanded polytetrafluoroethylene (PTFE) tube around a support wire or metal tube in the form of a coiled stent so that a hollow passageway is created between the metal and the PTFE. A drug is flowed into this space and slowly dispensed through the porous PTFE.
  • One embodiment of the hollow stent of the present invention comprises a shape memory metal such as nitinol. Shape memory metals are a group of metallic compositions that that have the ability to return to a defined shape or size when subjected to certain thermal or stress conditions. Shape memory metals are generally capable of being deformed at a relatively low temperature and, upon exposure to a relatively higher temperature, return to the defined shape or size they held prior to the deformation. This enables the stent to be inserted into the body in a deformed, smaller state so that it assumes its “remembered” larger shape once it is exposed to a higher temperature (i.e. body temperature or heated fluid) in vivo.
  • Special fittings are incorporated at the ends of the hollow stent. These fittings facilitate the injection and removal of fluid and also allow the stent to be detached from the insertion device to be left in place in a patient. The hollow stent has an inlet and an outlet so that a complete fluid path can be created, and fluid can be continually circulated through the stent. In the simplest configuration the inlet and outlet are at opposite ends of the stent. However, if the stent is equipped with a plurality of lumens, two lumens can be connected at a distal end of the structure so that the outlet and inlet are both together at one end. Other arrangements can be readily envisioned by one of ordinary skill in the art.
  • The stent is inserted into the body while connected to a catheter in a small, deformed state. Once inside the patient's body the stent is advanced to a desired position and expanded to its larger full size. If the stent is composed of shape memory metal, for example, the stent expands from its small-deformed state to its remembered larger state due to the higher body temperature or due to the passage of “hot” fluid through the stent. Subsequently “treatment” fluid (e.g., heated, cryogenic or radioactive) is pumped through the catheter to the stent where it is circulated throughout the stent, treating the adjacent vascular walls. The catheter can either be left in place for a certain period of time or removed, leaving the fluid inside the stent. This would particularly be the case with radioactive fluid or with a porous drug delivery stent.
  • The stent can be removed by reattaching the catheter allowing one to chill and shrink the stent (in the case of a memory alloy). Alternatively, the device can readily be used in its tethered form to remove memory alloy stents of the present invention or of prior art design. For this purpose a device of the present invention is inserted into the vasculature to rest within the stent to be removed. Warm fluid is then circulated causing the stent to expand into contact with the memory alloy stent that is already in position. At this point cryogenic (e.g., low temperature) fluid is circulated causing the attached stent and the contacted stent to shrink so that the combination can be readily withdrawn.
  • These and other embodiments, features and advantages of the present invention will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a hollow coiled stent.
  • FIG. 2 is a perspective view of a valve assembly to be used with FIG. 1.
  • FIG. 3 is a sectional view of the hollow stent tube of FIG. 2.
  • FIG. 4 is a representation of the stent of FIG. 1 in the position for treatment.
  • FIG. 5 is a sectional view of a second embodiment of a hollow coiled stent.
  • FIG. 6 is a perspective view of a second embodiment of a hollow coiled stent.
  • FIG. 7 is a perspective view of a third embodiment of a hollow coiled stent.
  • FIG. 8 is a perspective view of a valve assembly to be used with FIG. 6.
  • FIG. 9 is a perspective view of a fourth embodiment of a hollow coiled stent.
  • FIG. 10 is a sectional view of the hollow stent tube of FIG. 8.
  • FIG. 11 (11 a, 11 b, and 11 c) is an illustration of the method detailed in FIG. 12.
  • FIG. 12 is a flow diagram explaining use a stent of the present invention to a shape memory stent already in place.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected preferred embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
  • Referring now to the drawings, in which like reference numbers represent similar or identical structures throughout the drawings, FIG. 1 depicts a preferred embodiment of this invention. Pictured in FIG. 1 is a medical apparatus 10 comprising an endoluminal stent 20 attached to a delivery catheter 30 by means of a valve assembly 40. In this representation endoluminal stent 20 is generally coiled in shape leaving a tubular space down the center of its length. Obviously, the principle of a hollow stent can be applied to stents of a zigzag or other construction other than simply coiled. The tubing 22 of the stent 20 is preferably composed of a metal material that can be crimped onto a balloon catheter (not shown) for insertion into a body. Once positioned inside of the body at the desired location, the balloon can be inflated, bringing the stent from a compact small size to its enlarged full size thus opening a pathway for blood flow.
  • Inside the tubing 22 of stent 20, two fluid pathways exist. These pathways can be seen in the cross sectional view of FIG. 3. Pathways 26 and 28 have opposite flowing fluid streams and connect at the distal end 24 of stent 20. By allowing for opposite streams, radioactive, heated or cryogenic liquids can continuously flow through stent 20 for the purpose of killing or preventing proliferation of cells. By “heated” or “hot” is meant temperatures above body temperature. By “cryogenic” or “cold” is meant temperatures below body temperature. The stent 20 can either remain connected to a delivery catheter 30 for temporary insertion, or be detached for a more permanent insertion. In either case, fluid flow can be circulated throughout stent 20 prior to disconnection. In the simplest design, fluid passageways connected to the stent 20 are lumens of the delivery catheter so that when the catheter is withdrawn, fluid flow must cease.
  • It is also possible to provide separate flexible tubes that are threaded through the catheter so that the delivery catheter can be withdrawn leaving the relatively smaller fluid delivery tubes (not shown) behind. Preventing leakage of the fluid from the stent 20 after the catheter 30 is disconnected is accomplished through a valve mechanism contained in the catheter 30, or the stent 20 and/or both. In the example illustrated in FIG. 2 rubber or elastomer diaphragms 25 are penetrated by small hollow needles 48 in the valve assembly 40. In addition, the valve 40 may comprise a simple back flow preventer. Thus, when pressure is applied from incoming fluid to the valve assembly 40, a ball 45 which sits in a ball seat 44 is forced back against a spring 46 and the valve 40 opens for the incoming fluid pathway 28. A similar arrangement allows pressure to open the outgoing fluid pathway 26. A check ball valve is shown only as an example. Flap valves or any of a number of other back flow valve designs well known in the art can be employed. Complex systems in which a bayonet-type attachment automatically opens a valve are also possible.
  • The catheter 30 comprises a catheter shaft 32, which further contains two fluid pathways 34 and 36 as seen in FIG. 2. At the distal end of catheter 30, the valve assembly 40 has small hollow needles 48 that are designed to puncture elastomer diaphragms 25. The catheter 30 is slightly larger in diameter than the stent member 20 so that the catheter tubing wall 32 forms a friction fit over the stent wall 22. This creates a seal between the catheter 30, and the stent 20 for fluid delivery and removal. Upon detaching the catheter 30 leakage from the stent 20 is prevented due to the self-healing properties of the diaphragms 25. Obviously, the back flow preventer 40 could be on the stent 20 and the diaphragms could be on the catheter 30.
  • As discussed above, stent 20 is inserted into the body to the desired site through the use of a catheter insertion device well known in the art. FIG. 4 depicts stent 20 in its enlarged form after it has been inserted into the body at the affected location and expanded. Other means of stent expansion other than a balloon catheter are possible. If the stent 20 is formed from shape memory metal, such as Nitinol, the heat of the body can cause the stent 20 to assume a larger, remembered form. Alternatively, heated fluid can be circulated through the stent to cause it to recover its remembered form. A self-expanding stent made of a spring-type alloy can also be employed. In that case the delivery catheter would be equipped with means (e.g., an outer sheath) to keep the stent compressed until it was at the desired location.
  • By increasing the diameter of stent 20 at an affected location, the passageway is enlarged to permit increased blood flow. At the same time, fluids can pass through the interior of tubes 22 of the hollow stent 20 to treat the vascular wall. The walls of the vasculature can be treated by running either a radioactive, cryogenic or heated fluid through the stent 20 or by delivering a drug through a stent equipped for drug diffusion (e.g., through holes or a porous region).
  • FIG. 5 depicts a second embodiment of the invention. In this embodiment, the hollow stent 60 has only one fluid pathway 66, an inlet without an outlet, and is used to deliver drugs to affected areas. Once the stent 60 is inserted into place and is in its enlarged configuration, drugs are delivered through the catheter to the stent 60. Stent 60 can be constructed in various ways to facilitate the delivery of drugs. In one case, as shown in FIG. 6, the stent 60 is constructed with regions or segments that have pores 64 to allow drug seepage from the tubing 62. Alternatively, continuously porous metal, porous plastic, or a combination of metal and plastic can be used. The perforations 64 or slits in the stent to facilitate drug delivery must be of sufficiently small size to allow the passage of the drug through the entire length of the stent so that all areas can be treated. It will be apparent that pore size can control the rate at which the drug is dispensed. It is possible to cover the pores 64 with semi-permeable membrane to further control and restrict drug outflow. A semi-permeable membrane with inclusion of an osmotic agent with the drug will result in water uptake and more rapid and controlled pressurized delivery of the drug.
  • A third embodiment of the invention, FIG. 7, has a hollow stent 70 containing a single fluid pathway. The tubing 72 can be made of any of the materials discussed above, but in this embodiment, the stent 70 has an inlet path 78 that carries the fluid to the distal end 74 of stent 70 where it then runs through the coils. In this embodiment, a valve 80 connects the stent 70 to catheter 30. FIG. 8 shows a cross-sectional view of valve 80. The pressure from the liquid sent through the catheter causes the gate 82 of valve 80 to open to allow the fluid into the inlet path 78. The pressure that forces the opening of gate 82 causes the simultaneous opening of gate 84, allowing the fluid that is circulated through the stent 70 to exit through pathway 36 of catheter 30. The fluid entering and exiting through catheter 30 must also go through a check ball valve assembly similar to the one shown in FIG. 2. Again, flaps or other “one way” valve mechanisms can be applied. After all incoming fluid has been delivered to the stent 70, the absence of pressure causes gate 82 and gate 84 to close, thereby closing valve 80. This design can be used with any of the fluids mentioned above. The stent 70 can be used to circulate radioactive or cryogenic fluids for treatment of the vascular walls and can also be perforated for the delivery of drugs.
  • In a fourth embodiment, a hollow coiled stent 90 is formed from polytetrafluoroethylene (PTFE) 92. In FIG. 9, a perspective view of this embodiment can be seen. The stent 90 consists of a support wire 94 over which PTFE 92 is fitted. The pliable structure resulting is then formed into a coiled stent. The PTFE 92 is fitted around the wire 94 so that there is sufficient room to allow the passage of fluid. FIG. 10 shows a cross-sectional view of stent 90, illustrating the pathway 96 created around the support wire 94 to allow the passage of fluid. In this embodiment, stretched expanded PTFE can be used to create a porous stent to facilitate the delivery of drugs. The wire 94 can also be hollow (passageway 95) so that the stent 90 can simultaneously deliver drugs and radioactive fluid or temperature regulating fluid.
  • A fifth embodiment of the invention is illustrated in FIG. 11 and described in a flow diagram shown in FIG. 12. This embodiment is a method for recapturing an existing shape memory metal stent already in the body. With reference to both FIGS. 11 and 12, a shape memory metal stent A is inserted into the body in its small, deformed state through the use of an insertion device well known in the art in step 112. The inserted stent A in its deformed state is placed into the center of a memory alloy stent B that is already in an enlarged support position in the body in step 114. The deformed stent A is then enlarged so that it comes in contact with stent B. This can be accomplished in one of two ways. Either the stent A may enlarge due to the higher in vivo body temperature in step 115, or a hot liquid may be pumped through stent A to cause it to expand in step 116. Once expanded and in contact with stent B, cryogenic liquid may be pumped through stent A so that both stent A and stent B are chilled and either shrink down to their deformed states or become sufficiently relaxed to allow ready removal in step 118. Once in a small, deformed or relaxed state, stents A and B are easily removed from the body in step 119 by withdrawing the catheter attached to stent A. FIG. 11 a illustrates stent A in its reduced state being inserted into stent A. FIG. 11 b shows an enlarged version of stent A contacting stent B. Thereafter, a temperature change caused, for example, by fluid circulating through stent A will shrink both stents and enable their removal (FIG. 11 c).
  • Having thus described a preferred embodiment of a hollow endoluminal stent, it should be apparent to those skilled in the art that certain advantages of the within system have been achieved. It should also be appreciated that various modifications, adaptations, and alternative embodiments thereof may be made within the scope and spirit of the present invention. For example, a hollow stent with a coiled, tubular shape has been illustrated, however, many other possibilities exist for the shape and size of the hollow stent. In addition, the passageways are illustrated as round but could take on a variety of other shapes. The described embodiments are to be considered illustrative rather than restrictive. The invention is further defined by the following claims.

Claims (24)

1. A method of retrieving a stent, comprising:
positioning a portion of a first stent within a lumen of a second stent residing at a first location in a blood vessel;
contacting a surface of the second stent with the first stent; and
translating the first and second stents away from the first location.
2. The method according to claim 1, wherein the first stent is comprised of a shape-memory material and the contacting step comprises the step of expanding the first stent from a contracted diameter to an expanded diameter by circulating heated fluid through a fluid flow conduit of the first stent, the method further comprising the step of contracting the first and second stents concomitantly by delivering a cryogenic fluid to the first stent.
3. The method according to claim 1, wherein the first stent is connected to a catheter comprising a valve for controlling fluid flow to and from the first stent, the contacting step comprising the step of delivering fluid through the catheter and valve to the first stent to expand the first stent.
4. The method according to claim 3, wherein the first stent comprises a single fluid pathway having a first end and a second end in fluid communication respectively with a first and second lumen of the catheter, the delivering step comprising circulating fluid through the first stent by delivering fluid from the catheter first lumen to the first end of the first stent and from the second end of the first stent to the catheter second lumen.
5. The method according to claim 3, wherein the first stent comprises a first and second fluid pathway in fluid communication respectively with a first and second lumen of the catheter, the delivering step comprising circulating fluid through the first stent by delivering fluid from the catheter first lumen to the first fluid pathway of the first stent and from the second fluid pathway of the first stent to the catheter second lumen.
6. The method according to claim 5, wherein the first and second fluid pathways are connected at a distal end of the first stent, the circulating step comprising fluid from the first fluid pathway entering the second fluid pathway at the distal end of the first stent.
7. The method according to claim 1, wherein the first stent is connected to a catheter comprising a valve assembly for delivering fluid to and from the first stent, the valve assembly comprising a first and second hollow member configured for insertion through a diaphragm of the first stent, the first and second hollow member being in fluid communication with a first and second lumen of the catheter, the contacting step comprising the step of delivering fluid through the first lumen of the catheter and the first hollow member to the first stent to expand the first stent.
8. The method according to claim 7, wherein the delivering step further comprises removing fluid from the first stent through the second hollow member and through the second lumen of the catheter.
9. The method according to claim 1, wherein the first and second stents are comprised of a shape memory material, further comprising the step of collapsing the first and second stents concomitantly, following the contacting step.
10. The method according to claim 9, wherein the first and second stents are comprised of a shape memory metal, wherein the collapsing step comprises the step of introducing a cryogenic fluid into the first stent.
11. The method according to claim 10, wherein the first stent is connected to a catheter comprising a valve for controlling fluid flow to and from the first stent, the contacting step comprising the step of delivering fluid through the catheter and valve to the first stent to expand the first stent.
12. The method according to claim 11, wherein the first stent comprises a single fluid pathway having a first end and a second end in fluid communication respectively with a first and second lumen of the catheter, the delivering step comprising circulating fluid through the first stent by delivering fluid from the catheter first lumen to the first end of the first stent and from the second end of the first stent to the catheter second lumen.
13. The method according to claim 11, wherein the first stent comprises a first and second fluid pathway in fluid communication respectively with a first and second lumen of the catheter, the delivering step comprising circulating fluid through the first stent by delivering fluid from the catheter first lumen to the first fluid pathway of the first stent and from the second fluid pathway of the first stent to the catheter second lumen.
14. The method according to claim 13, wherein the first and second fluid pathways are connected at a distal end of the first stent, the circulating step comprising fluid from the first fluid pathway entering the second fluid pathway at the distal end of the first stent.
15. The method according to claim 9, wherein the first stent is connected to a catheter comprising a valve assembly for delivering fluid to and from the first stent, the valve assembly comprising a first and second hollow member configured for insertion through a diaphragm of the first stent, the first and second hollow member being in fluid communication with a first and second lumen of the catheter, the contacting step comprising the step of delivering fluid through the first lumen of the catheter and the first hollow member to the first stent to expand the first stent.
16. The method according to claim 15, wherein the delivering step further comprises removing fluid from the first stent through the second hollow member and through the second lumen of the catheter.
17. The method according to claim 1, wherein the contacting step comprises expanding the first stent from a contracted diameter to an expanded diameter by heating the first stent, the method further comprising the step of contracting the first and second stents concomitantly to a diameter smaller than the expanded diameter by cooling the first stent.
18. A method of retrieving a stent, comprising:
positioning a portion of a first shape memory stent attached to a catheter within a lumen of a second shape memory stent deployed in a blood vessel;
delivering heated fluid from the catheter to the first stent to cause the first stent to expand from a contracted diameter to an expanded diameter, a surface of the first stent contacting a surface of the second stent;
introducing a cryogenic fluid into the first stent to cause the first and second stents to contract to a removal diameter; and
removing the first and second stents from the blood vessel.
19. A stent comprising a non-inflatable non-porous tubing, including at least one fluid flow conduit therein, the tubing being circumferentially arranged to form a side wall of the stent, thereby creating a main lumen of the stent through which blood can flow.
20. The stent according to claim 19, wherein the stent is comprised of a shape memory material.
21. The stent according to claim 20, wherein the shape memory material comprises a metal.
22. The stent according to claim 20, wherein the shape memory material comprises a plastic.
23. The stent according to claim 19, further comprising:
a removable catheter including a proximal end that remains outside of a patient's body and a distal end that is capable of sealing attachment to the stent for fluid delivery to the stent; and
a valve for controlling the flow of fluid in the system.
24. The stent according to claim 23, wherein the valve comprises a back flow preventer.
US11/109,604 1998-09-30 2005-04-19 Method of recapturing a stent Abandoned US20050187612A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/109,604 US20050187612A1 (en) 1998-09-30 2005-04-19 Method of recapturing a stent

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10576898P 1998-09-30 1998-09-30
US09/321,496 US6358276B1 (en) 1998-09-30 1999-05-27 Fluid containing endoluminal stent
US09/975,743 US6623519B2 (en) 1998-09-30 2001-10-11 Fluid containing endoluminal stent
US10/638,182 US6881220B2 (en) 1998-09-30 2003-08-08 Method of recapturing a stent
US11/109,604 US20050187612A1 (en) 1998-09-30 2005-04-19 Method of recapturing a stent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/638,182 Continuation US6881220B2 (en) 1998-09-30 2003-08-08 Method of recapturing a stent

Publications (1)

Publication Number Publication Date
US20050187612A1 true US20050187612A1 (en) 2005-08-25

Family

ID=26802921

Family Applications (4)

Application Number Title Priority Date Filing Date
US09/321,496 Expired - Lifetime US6358276B1 (en) 1998-09-30 1999-05-27 Fluid containing endoluminal stent
US09/975,743 Expired - Lifetime US6623519B2 (en) 1998-09-30 2001-10-11 Fluid containing endoluminal stent
US10/638,182 Expired - Fee Related US6881220B2 (en) 1998-09-30 2003-08-08 Method of recapturing a stent
US11/109,604 Abandoned US20050187612A1 (en) 1998-09-30 2005-04-19 Method of recapturing a stent

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/321,496 Expired - Lifetime US6358276B1 (en) 1998-09-30 1999-05-27 Fluid containing endoluminal stent
US09/975,743 Expired - Lifetime US6623519B2 (en) 1998-09-30 2001-10-11 Fluid containing endoluminal stent
US10/638,182 Expired - Fee Related US6881220B2 (en) 1998-09-30 2003-08-08 Method of recapturing a stent

Country Status (8)

Country Link
US (4) US6358276B1 (en)
EP (2) EP1520556B9 (en)
JP (2) JP4295436B2 (en)
CA (1) CA2345614A1 (en)
DE (2) DE69938516T2 (en)
ES (1) ES2241325T3 (en)
MX (1) MXPA01003280A (en)
WO (1) WO2000018327A1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060184231A1 (en) * 2005-02-08 2006-08-17 Rucker Brian K Self contracting stent
US20060211984A1 (en) * 2003-09-23 2006-09-21 C. R. Bard, Inc. Implant with shape memory
US20080215131A1 (en) * 2006-12-04 2008-09-04 Cook Incorporated Method for loading a medical device into a delivery system
US20100022951A1 (en) * 2008-05-19 2010-01-28 Luce, Forward, Hamilton 7 Scripps, Llp Detachable hub/luer device and processes
US20110137398A1 (en) * 2008-04-23 2011-06-09 Cook Inc. Method of loading a medical device into a delivery system
US8066757B2 (en) 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US20120101560A1 (en) * 2010-10-26 2012-04-26 Kluck Bryan W Retractable flow maintaining stent wire
CN102596279A (en) * 2009-09-20 2012-07-18 麦德托尼克瓦斯科尔勒公司 Method of forming hollow tubular drug eluting medical devices
US8545514B2 (en) 2008-04-11 2013-10-01 Covidien Lp Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US8926680B2 (en) 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US20150073526A1 (en) * 2010-10-26 2015-03-12 Bryan W Kluck Retractable Flow Maintaining Stent
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
WO2018126211A1 (en) * 2016-12-30 2018-07-05 Zoll Circulation, Inc. High efficiency heat exchange catheters for control of patient body temperature
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US10912933B2 (en) 2014-08-19 2021-02-09 The Regents Of The University Of California Implants for localized drug delivery and methods of use thereof
US11060480B2 (en) 2017-11-14 2021-07-13 The Boeing Company Sound-attenuating heat exchangers and methods of utilizing the same
US11143170B2 (en) * 2019-06-28 2021-10-12 The Boeing Company Shape memory alloy lifting tubes and shape memory alloy actuators including the same
US11168584B2 (en) 2019-06-28 2021-11-09 The Boeing Company Thermal management system using shape memory alloy actuator
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11525438B2 (en) 2019-06-28 2022-12-13 The Boeing Company Shape memory alloy actuators and thermal management systems including the same

Families Citing this family (218)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358276B1 (en) * 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6063101A (en) * 1998-11-20 2000-05-16 Precision Vascular Systems, Inc. Stent apparatus and method
GB9828696D0 (en) * 1998-12-29 1999-02-17 Houston J G Blood-flow tubing
US6733513B2 (en) 1999-11-04 2004-05-11 Advanced Bioprosthetic Surfaces, Ltd. Balloon catheter having metal balloon and method of making same
US8458879B2 (en) 2001-07-03 2013-06-11 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Method of fabricating an implantable medical device
US20050238686A1 (en) * 1999-12-23 2005-10-27 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US6658288B1 (en) * 2000-05-05 2003-12-02 Endovascular Technologies, Inc. Apparatus and method for aiding thrombosis through the application of electric potential
US8252044B1 (en) 2000-11-17 2012-08-28 Advanced Bio Prosthestic Surfaces, Ltd. Device for in vivo delivery of bioactive agents and method of manufacture thereof
US6974473B2 (en) 2000-06-30 2005-12-13 Vascular Architects, Inc. Function-enhanced thrombolytic AV fistula and method
CN1447669A (en) 2000-08-18 2003-10-08 阿特里泰克公司 Expandable implant devices for filtering blood flow from atrial appendages
US6602288B1 (en) * 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US9107605B2 (en) 2000-11-17 2015-08-18 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Device for in vivo delivery of bioactive agents and method of manufacture thereof
US10398830B2 (en) 2000-11-17 2019-09-03 Vactronix Scientific, Llc Device for in vivo delivery of bioactive agents and method of manufacture thereof
KR100994543B1 (en) 2001-02-16 2010-11-16 아스텔라스세이야쿠 가부시키가이샤 506 implants with fk506
US6837901B2 (en) * 2001-04-27 2005-01-04 Intek Technology L.L.C. Methods for delivering, repositioning and/or retrieving self-expanding stents
US6800090B2 (en) * 2001-05-14 2004-10-05 Cardiac Dimensions, Inc. Mitral valve therapy device, system and method
WO2003002243A2 (en) 2001-06-27 2003-01-09 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US7635387B2 (en) * 2001-11-01 2009-12-22 Cardiac Dimensions, Inc. Adjustable height focal tissue deflector
US6824562B2 (en) 2002-05-08 2004-11-30 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US6976995B2 (en) 2002-01-30 2005-12-20 Cardiac Dimensions, Inc. Fixed length anchor and pull mitral valve device and method
US7179282B2 (en) * 2001-12-05 2007-02-20 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US6908478B2 (en) * 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method
US20050209690A1 (en) * 2002-01-30 2005-09-22 Mathis Mark L Body lumen shaping device with cardiac leads
CA2877641C (en) * 2002-05-08 2017-01-17 Cardiac Dimensions Pty. Ltd. Device and method for modifying the shape of a body organ
WO2004004602A1 (en) * 2002-07-08 2004-01-15 Abbott Laboratories Vascular Enterprises Limited Drug eluting stent and methods of manufacture
AU2003270817B2 (en) 2002-09-26 2009-09-17 Vactronix Scientific, Llc High strength vacuum deposited nitionol alloy films, medical thin film graft materials and method of making same
US20040088038A1 (en) * 2002-10-30 2004-05-06 Houdin Dehnad Porous metal for drug-loaded stents
US20060271168A1 (en) * 2002-10-30 2006-11-30 Klaus Kleine Degradable medical device
US7837729B2 (en) * 2002-12-05 2010-11-23 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty delivery system
US7316708B2 (en) * 2002-12-05 2008-01-08 Cardiac Dimensions, Inc. Medical device delivery system
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7314485B2 (en) * 2003-02-03 2008-01-01 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040193246A1 (en) * 2003-03-25 2004-09-30 Microvention, Inc. Methods and apparatus for treating aneurysms and other vascular defects
US6777647B1 (en) * 2003-04-16 2004-08-17 Scimed Life Systems, Inc. Combination laser cutter and cleaner
US20040220654A1 (en) 2003-05-02 2004-11-04 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7887582B2 (en) * 2003-06-05 2011-02-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7488343B2 (en) * 2003-09-16 2009-02-10 Boston Scientific Scimed, Inc. Medical devices
US20060271174A1 (en) * 2003-12-19 2006-11-30 Gregory Nieminen Mitral Valve Annuloplasty Device with Wide Anchor
US7837728B2 (en) 2003-12-19 2010-11-23 Cardiac Dimensions, Inc. Reduced length tissue shaping device
US7794496B2 (en) * 2003-12-19 2010-09-14 Cardiac Dimensions, Inc. Tissue shaping device with integral connector and crimp
US20050137449A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. Tissue shaping device with self-expanding anchors
US9526616B2 (en) * 2003-12-19 2016-12-27 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US20050137687A1 (en) 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US7824443B2 (en) * 2003-12-23 2010-11-02 Sadra Medical, Inc. Medical implant delivery and deployment tool
US20120041550A1 (en) 2003-12-23 2012-02-16 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8287584B2 (en) 2005-11-14 2012-10-16 Sadra Medical, Inc. Medical implant deployment tool
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8951299B2 (en) 2003-12-23 2015-02-10 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
EP2529699B1 (en) 2003-12-23 2014-01-29 Sadra Medical, Inc. Repositionable heart valve
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
US7824442B2 (en) * 2003-12-23 2010-11-02 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
WO2005077450A2 (en) * 2004-02-10 2005-08-25 Synecor, Llc Intravascular delivery system for therapeutic agents
US8137397B2 (en) * 2004-02-26 2012-03-20 Boston Scientific Scimed, Inc. Medical devices
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8092549B2 (en) 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
US9801527B2 (en) 2004-04-19 2017-10-31 Gearbox, Llc Lumen-traveling biological interface device
US8361013B2 (en) 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US7850676B2 (en) 2004-04-19 2010-12-14 The Invention Science Fund I, Llc System with a reservoir for perfusion management
US8337482B2 (en) 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US8000784B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling device
US8024036B2 (en) 2007-03-19 2011-09-20 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US7998060B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling delivery device
US8177760B2 (en) 2004-05-12 2012-05-15 C. R. Bard, Inc. Valved connector
WO2006015111A2 (en) * 2004-07-27 2006-02-09 University Of Southern California Percutaneously retrievable stent assembly with fluid draining capability
US7063720B2 (en) * 2004-09-14 2006-06-20 The Wallace Enterprises, Inc. Covered stent with controlled therapeutic agent diffusion
US7824416B2 (en) * 2004-10-06 2010-11-02 Boston Scientific Scimed, Inc. Medical retrieval device
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
AU2006206254B2 (en) 2005-01-20 2012-02-09 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US8460357B2 (en) * 2005-05-31 2013-06-11 J.W. Medical Systems Ltd. In situ stent formation
US8038704B2 (en) 2005-07-27 2011-10-18 Paul S. Sherburne Stent and other objects removal from a body
US7712606B2 (en) 2005-09-13 2010-05-11 Sadra Medical, Inc. Two-part package for medical implant
GB0521585D0 (en) * 2005-10-22 2005-11-30 Depuy Int Ltd A spinal support rod
GB0521582D0 (en) * 2005-10-22 2005-11-30 Depuy Int Ltd An implant for supporting a spinal column
EP1779821A1 (en) * 2005-10-26 2007-05-02 Etervind AB Adjustable gastric band
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
GB0600662D0 (en) * 2006-01-13 2006-02-22 Depuy Int Ltd Spinal support rod kit
US8348952B2 (en) * 2006-01-26 2013-01-08 Depuy International Ltd. System and method for cooling a spinal correction device comprising a shape memory material for corrective spinal surgery
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
EP1988851A2 (en) 2006-02-14 2008-11-12 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US20070225799A1 (en) * 2006-03-24 2007-09-27 Medtronic Vascular, Inc. Stent, intraluminal stent delivery system, and method of treating a vascular condition
US7503932B2 (en) * 2006-04-11 2009-03-17 Cardiac Dimensions, Inc. Mitral valve annuloplasty device with vena cava anchor
US20080058788A1 (en) 2006-04-12 2008-03-06 Searete Llc., A Limited Liability Corporation Of The State Of Delaware Autofluorescent imaging and target ablation
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US9198563B2 (en) 2006-04-12 2015-12-01 The Invention Science Fund I, Llc Temporal control of a lumen traveling device in a body tube tree
US20100030251A1 (en) * 2006-05-24 2010-02-04 Mayo Foundation For Medical Education And Research Devices and methods for crossing chronic total occlusions
US11285005B2 (en) 2006-07-17 2022-03-29 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
EP2054537A2 (en) * 2006-08-02 2009-05-06 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
EP2081616B1 (en) 2006-09-15 2017-11-01 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
JP2010503494A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Biodegradable endoprosthesis and method for producing the same
WO2008034047A2 (en) * 2006-09-15 2008-03-20 Boston Scientific Limited Endoprosthesis with adjustable surface features
EP2210625B8 (en) * 2006-09-15 2012-02-29 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis with biostable inorganic layers
CA2663220A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices and methods of making the same
US20080071358A1 (en) * 2006-09-18 2008-03-20 Boston Scientific Scimed, Inc. Endoprostheses
US8002821B2 (en) 2006-09-18 2011-08-23 Boston Scientific Scimed, Inc. Bioerodible metallic ENDOPROSTHESES
US20080097577A1 (en) * 2006-10-20 2008-04-24 Boston Scientific Scimed, Inc. Medical device hydrogen surface treatment by electrochemical reduction
ES2506144T3 (en) 2006-12-28 2014-10-13 Boston Scientific Limited Bioerodible endoprosthesis and their manufacturing procedure
WO2008098926A1 (en) * 2007-02-13 2008-08-21 Cinvention Ag Reservoir implants and stents
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
EP2162101B1 (en) 2007-06-25 2019-02-20 MicroVention, Inc. Self-expanding prosthesis
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
CN101917929A (en) 2007-10-04 2010-12-15 特里瓦斯库拉尔公司 Modular vascular graft for low profile percutaneous delivery
US20090093871A1 (en) * 2007-10-08 2009-04-09 Medtronic Vascular, Inc. Medical Implant With Internal Drug Delivery System
GB0720762D0 (en) 2007-10-24 2007-12-05 Depuy Spine Sorl Assembly for orthopaedic surgery
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8016880B2 (en) 2007-11-16 2011-09-13 Medtronic Vascular, Inc. Stent having spiral channel for drug delivery
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
DE102008002397A1 (en) * 2008-06-12 2009-12-17 Biotronik Vi Patent Ag Implantable device
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8006594B2 (en) * 2008-08-11 2011-08-30 Cardiac Dimensions, Inc. Catheter cutting tool
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
EP2403546A2 (en) 2009-03-02 2012-01-11 Boston Scientific Scimed, Inc. Self-buffering medical implants
US20100261662A1 (en) * 2009-04-09 2010-10-14 Endologix, Inc. Utilization of mural thrombus for local drug delivery into vascular tissue
US7942917B2 (en) * 2009-04-17 2011-05-17 Medtronic Vascular, Inc. Hollow helical stent system
US9283305B2 (en) 2009-07-09 2016-03-15 Medtronic Vascular, Inc. Hollow tubular drug eluting medical devices
US8460745B2 (en) * 2009-09-20 2013-06-11 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8828474B2 (en) 2009-09-20 2014-09-09 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
CN103002833B (en) 2010-05-25 2016-05-11 耶拿阀门科技公司 Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese
CN106073946B (en) 2010-09-10 2022-01-04 西美蒂斯股份公司 Valve replacement device, delivery device for a valve replacement device and method of producing a valve replacement device
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
US8632846B2 (en) 2010-09-17 2014-01-21 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US20130280755A1 (en) * 2010-11-23 2013-10-24 Fred Hutchinson Cancer Research Center Therapeutic methods for solid delivery
US8936827B2 (en) 2011-02-25 2015-01-20 Abbott Cardiovascular Systems Inc. Methods of loading a hollow stent with a drug or drug formulation
US8927047B2 (en) 2011-02-25 2015-01-06 Abbott Cardiovascular Systems Inc. Methods of drug loading a hollow stent with a high viscosity formulation
US9585780B2 (en) 2011-02-25 2017-03-07 Abbott Cardiovascular Systems Inc. Pressure chamber and apparatus for loading material into a stent strut
US20120216908A1 (en) 2011-02-25 2012-08-30 Abbott Cardiovascular Systems Inc. Methods Of Drug Loading A Hollow Stent By Immersion
US9238514B2 (en) 2011-02-25 2016-01-19 Abbott Cardiovascular Systems Inc. Vacuum chamber and apparatus for loading material into a stent strut
US8757219B2 (en) 2011-02-25 2014-06-24 Abbott Cardiovascular Systems Inc. Suction pump and apparatus for loading material into a stent strut
US8733408B2 (en) 2011-02-25 2014-05-27 Abbott Cardiovascular Systems Inc. Cover sleeve and apparatus for loading material into a stent strut
EP4119095A1 (en) 2011-03-21 2023-01-18 Cephea Valve Technologies, Inc. Disk-based valve apparatus
EP2520251A1 (en) 2011-05-05 2012-11-07 Symetis SA Method and Apparatus for Compressing Stent-Valves
WO2013009975A1 (en) 2011-07-12 2013-01-17 Boston Scientific Scimed, Inc. Coupling system for medical devices
US10045881B2 (en) * 2011-09-28 2018-08-14 Zoll Circulation, Inc. Patient temperature control catheter with helical heat exchange paths
CN104023760A (en) 2011-10-28 2014-09-03 普莱萨格生命科学公司 Methods for drug delivery
US9131926B2 (en) 2011-11-10 2015-09-15 Boston Scientific Scimed, Inc. Direct connect flush system
US8940014B2 (en) 2011-11-15 2015-01-27 Boston Scientific Scimed, Inc. Bond between components of a medical device
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
US9277993B2 (en) 2011-12-20 2016-03-08 Boston Scientific Scimed, Inc. Medical device delivery systems
US9510945B2 (en) 2011-12-20 2016-12-06 Boston Scientific Scimed Inc. Medical device handle
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US8998977B2 (en) 2012-04-13 2015-04-07 Medtronic Vascular, Inc. Hollow drug-filled stent and method of forming hollow drug-filled stent
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
US9155645B2 (en) 2012-06-26 2015-10-13 Abbott Cardiovascular Systems Inc. Implantable prosthesis with radiopaque particles and method of making same
US9149375B2 (en) 2012-06-26 2015-10-06 Abbott Cardiovascular Systems Inc. Radiopaque drug-filled prosthesis and method of making same
WO2014151906A1 (en) 2013-03-14 2014-09-25 Medtronic Vascular Inc. Method for manufacturing a stent and stent manufactured thereby
US9901663B2 (en) 2013-05-06 2018-02-27 Abbott Cardiovascular Systems Inc. Hollow stent filled with a therapeutic agent formulation
US9561103B2 (en) 2013-07-17 2017-02-07 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
JP6563394B2 (en) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド Radially foldable frame for an artificial valve and method for manufacturing the frame
WO2015061801A2 (en) * 2013-10-26 2015-04-30 Accumed Radial Systems Llc System, apparatus, and method for creating a lumen
CN103932751B (en) * 2014-01-23 2016-03-30 赵雨辰 Filling administration drainage stent in a kind of body
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
WO2016093877A1 (en) 2014-12-09 2016-06-16 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
JP6767388B2 (en) 2015-05-01 2020-10-14 イェーナヴァルヴ テクノロジー インコーポレイテッド Devices and methods to reduce the proportion of pacemakers in heart valve replacement
EP3294221B1 (en) 2015-05-14 2024-03-06 Cephea Valve Technologies, Inc. Replacement mitral valves
WO2016183523A1 (en) 2015-05-14 2016-11-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10314707B2 (en) 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US10335277B2 (en) 2015-07-02 2019-07-02 Boston Scientific Scimed Inc. Adjustable nosecone
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10779940B2 (en) 2015-09-03 2020-09-22 Boston Scientific Scimed, Inc. Medical device handle
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US10245136B2 (en) 2016-05-13 2019-04-02 Boston Scientific Scimed Inc. Containment vessel with implant sheathing guide
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
CA3051272C (en) 2017-01-23 2023-08-22 Cephea Valve Technologies, Inc. Replacement mitral valves
AU2018203053B2 (en) 2017-01-23 2020-03-05 Cephea Valve Technologies, Inc. Replacement mitral valves
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
US10390953B2 (en) 2017-03-08 2019-08-27 Cardiac Dimensions Pty. Ltd. Methods and devices for reducing paravalvular leakage
US10828154B2 (en) 2017-06-08 2020-11-10 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
WO2019028161A1 (en) 2017-08-01 2019-02-07 Boston Scientific Scimed, Inc. Medical implant locking mechanism
US10939996B2 (en) 2017-08-16 2021-03-09 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
WO2019144071A1 (en) 2018-01-19 2019-07-25 Boston Scientific Scimed, Inc. Medical device delivery system with feedback loop
WO2019144069A2 (en) 2018-01-19 2019-07-25 Boston Scientific Scimed, Inc. Inductance mode deployment sensors for transcatheter valve system
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
US11439732B2 (en) 2018-02-26 2022-09-13 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11229517B2 (en) 2018-05-15 2022-01-25 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
WO2019241477A1 (en) 2018-06-13 2019-12-19 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
US11241312B2 (en) 2018-12-10 2022-02-08 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
AU2021400419A1 (en) 2020-12-14 2023-06-29 Cardiac Dimensions Pty. Ltd. Modular pre-loaded medical implants and delivery systems

Citations (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3765032A (en) * 1972-09-27 1973-10-16 J Palma Implant
US3868856A (en) * 1973-04-25 1975-03-04 Nasa Instrumentation for measurement of air-craft noise and sonic boom
US4307723A (en) * 1978-04-07 1981-12-29 Medical Engineering Corporation Externally grooved ureteral stent
US4496349A (en) * 1981-05-08 1985-01-29 Renal Systems, Inc. Percutaneous implant
US4496350A (en) * 1980-04-08 1985-01-29 Renal Systems, Inc. Blood access device
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4531933A (en) * 1982-12-07 1985-07-30 C. R. Bard, Inc. Helical ureteral stent
US4694838A (en) * 1984-01-30 1987-09-22 Mallinckrodt, Inc. Loop coronary catheter
US4706671A (en) * 1985-05-02 1987-11-17 Weinrib Harry P Catheter with coiled tip
US4762130A (en) * 1987-01-15 1988-08-09 Thomas J. Fogarty Catheter with corkscrew-like balloon
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4881939A (en) * 1985-02-19 1989-11-21 The Johns Hopkins University Implantable helical cuff
US4887996A (en) * 1987-02-13 1989-12-19 Stig Bengmark Method and tube equipment for supplying fluid to a space and draining said space
US4917666A (en) * 1988-11-14 1990-04-17 Medtronic Versaflex, Inc. Steerable thru-lumen catheter
US5013304A (en) * 1989-02-22 1991-05-07 Bfd, Inc. Intravascular catheter assembly
US5147370A (en) * 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5158620A (en) * 1989-06-08 1992-10-27 Composite Materials Technology, Inc. Superconductor and process of manufacture
US5163928A (en) * 1991-01-07 1992-11-17 Franklin Electronic Publishers, Incorporated Self-centering catheter
US5167239A (en) * 1991-05-30 1992-12-01 Endomedix Corporation Anchorable guidewire
US5181911A (en) * 1991-04-22 1993-01-26 Shturman Technologies, Inc. Helical balloon perfusion angioplasty catheter
US5201901A (en) * 1987-10-08 1993-04-13 Terumo Kabushiki Kaisha Expansion unit and apparatus for expanding tubular organ lumen
US5226888A (en) * 1991-10-25 1993-07-13 Michelle Arney Coiled, perfusion balloon catheter
US5256146A (en) * 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US5370691A (en) * 1993-01-26 1994-12-06 Target Therapeutics, Inc. Intravascular inflatable stent
US5380307A (en) * 1992-09-30 1995-01-10 Target Therapeutics, Inc. Catheter with atraumatic drug delivery tip
US5441516A (en) * 1994-03-03 1995-08-15 Scimed Lifesystems Inc. Temporary stent
US5445594A (en) * 1994-04-05 1995-08-29 Elist; James J. Implant for expanding penile girth and length
US5536274A (en) * 1991-02-15 1996-07-16 pfm Produkterfur Die Medizin Spiral implant for organ pathways
US5545135A (en) * 1994-10-31 1996-08-13 Boston Scientific Corporation Perfusion balloon stent
US5562641A (en) * 1993-05-28 1996-10-08 A Bromberg & Co. Ltd. Two way shape memory alloy medical stent
US5649978A (en) * 1993-05-11 1997-07-22 Target Therapeutics, Inc. Temporary inflatable intravascular prosthesis
US5669931A (en) * 1995-03-30 1997-09-23 Target Therapeutics, Inc. Liquid coils with secondary shape
US5676685A (en) * 1995-06-22 1997-10-14 Razavi; Ali Temporary stent
US5697968A (en) * 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US5709874A (en) * 1993-04-14 1998-01-20 Emory University Device for local drug delivery and methods for using the same
US5716410A (en) * 1993-04-30 1998-02-10 Scimed Life Systems, Inc. Temporary stent and method of use
US5882335A (en) * 1994-09-12 1999-03-16 Cordis Corporation Retrievable drug delivery stent
US5902268A (en) * 1990-05-11 1999-05-11 Saab; Mark A. Heat transfer catheter apparatus and method of making and using same
US6050986A (en) * 1997-12-01 2000-04-18 Scimed Life Systems, Inc. Catheter system for the delivery of a low volume liquid bolus
US6053900A (en) * 1996-02-16 2000-04-25 Brown; Joe E. Apparatus and method for delivering diagnostic and therapeutic agents intravascularly
US6059823A (en) * 1996-02-13 2000-05-09 Scimed Life Systems, Inc. Endovascular apparatus
US6063101A (en) * 1998-11-20 2000-05-16 Precision Vascular Systems, Inc. Stent apparatus and method
US6149677A (en) * 1998-03-31 2000-11-21 Innercool Therapies, Inc. Circulating fluid hypothermia method
US6176871B1 (en) * 1993-04-28 2001-01-23 Focal, Inc. Apparatus and methods for intraluminal photothermoforming
US6258118B1 (en) * 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
US6348067B1 (en) * 1998-11-25 2002-02-19 Israel Aircraft Industries Ltd. Method and system with shape memory heating apparatus for temporarily supporting a tubular organ
US6358276B1 (en) * 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6383210B1 (en) * 2000-06-02 2002-05-07 Innercool Therapies, Inc. Method for determining the effective thermal mass of a body or organ using cooling catheter
US6413273B1 (en) * 1998-11-25 2002-07-02 Israel Aircraft Industries Ltd. Method and system for temporarily supporting a tubular organ
US20020161427A1 (en) * 2001-04-27 2002-10-31 Dmitry Rabkin Methods for delivering, repositioning and/or retrieving self-expanding stents
US6579305B1 (en) * 1995-12-07 2003-06-17 Medtronic Ave, Inc. Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material
US6607551B1 (en) * 1999-05-20 2003-08-19 Scimed Life Systems, Inc. Stent delivery system with nested stabilizer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868956A (en) 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
EP0441516B1 (en) * 1990-02-08 1995-03-29 Howmedica Inc. Inflatable stent
JPH04314438A (en) * 1991-01-14 1992-11-05 Olympus Optical Co Ltd Implanted device for medical treatment
US5156620A (en) 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
US5534024A (en) * 1994-11-04 1996-07-09 Aeroquip Corporation Intraluminal stenting graft
EP0812165A4 (en) 1995-02-27 2000-01-19 Instent Inc Hollow stent
ZA9710342B (en) * 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
EP2298241A3 (en) * 1996-12-03 2011-11-02 Atrium Medical Corporation Multi-stage prothesis
EP1600125A3 (en) * 1998-09-29 2006-08-30 C.R.Bard, Inc. Coiled stent for drug delivery

Patent Citations (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3765032A (en) * 1972-09-27 1973-10-16 J Palma Implant
US3868856A (en) * 1973-04-25 1975-03-04 Nasa Instrumentation for measurement of air-craft noise and sonic boom
US4307723A (en) * 1978-04-07 1981-12-29 Medical Engineering Corporation Externally grooved ureteral stent
US4496350A (en) * 1980-04-08 1985-01-29 Renal Systems, Inc. Blood access device
US4496349A (en) * 1981-05-08 1985-01-29 Renal Systems, Inc. Percutaneous implant
US4531933A (en) * 1982-12-07 1985-07-30 C. R. Bard, Inc. Helical ureteral stent
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4694838A (en) * 1984-01-30 1987-09-22 Mallinckrodt, Inc. Loop coronary catheter
US4881939A (en) * 1985-02-19 1989-11-21 The Johns Hopkins University Implantable helical cuff
US4706671A (en) * 1985-05-02 1987-11-17 Weinrib Harry P Catheter with coiled tip
US4762130A (en) * 1987-01-15 1988-08-09 Thomas J. Fogarty Catheter with corkscrew-like balloon
US4887996A (en) * 1987-02-13 1989-12-19 Stig Bengmark Method and tube equipment for supplying fluid to a space and draining said space
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US5201901A (en) * 1987-10-08 1993-04-13 Terumo Kabushiki Kaisha Expansion unit and apparatus for expanding tubular organ lumen
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4917666A (en) * 1988-11-14 1990-04-17 Medtronic Versaflex, Inc. Steerable thru-lumen catheter
US5013304A (en) * 1989-02-22 1991-05-07 Bfd, Inc. Intravascular catheter assembly
US5158620A (en) * 1989-06-08 1992-10-27 Composite Materials Technology, Inc. Superconductor and process of manufacture
US5902268A (en) * 1990-05-11 1999-05-11 Saab; Mark A. Heat transfer catheter apparatus and method of making and using same
US5163928A (en) * 1991-01-07 1992-11-17 Franklin Electronic Publishers, Incorporated Self-centering catheter
US5536274A (en) * 1991-02-15 1996-07-16 pfm Produkterfur Die Medizin Spiral implant for organ pathways
US5181911A (en) * 1991-04-22 1993-01-26 Shturman Technologies, Inc. Helical balloon perfusion angioplasty catheter
US5167239A (en) * 1991-05-30 1992-12-01 Endomedix Corporation Anchorable guidewire
US5147370A (en) * 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5256146A (en) * 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature
US5226888A (en) * 1991-10-25 1993-07-13 Michelle Arney Coiled, perfusion balloon catheter
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US5380307A (en) * 1992-09-30 1995-01-10 Target Therapeutics, Inc. Catheter with atraumatic drug delivery tip
US5370691A (en) * 1993-01-26 1994-12-06 Target Therapeutics, Inc. Intravascular inflatable stent
US5709874A (en) * 1993-04-14 1998-01-20 Emory University Device for local drug delivery and methods for using the same
US6176871B1 (en) * 1993-04-28 2001-01-23 Focal, Inc. Apparatus and methods for intraluminal photothermoforming
US5795318A (en) * 1993-04-30 1998-08-18 Scimed Life Systems, Inc. Method for delivering drugs to a vascular site
US5716410A (en) * 1993-04-30 1998-02-10 Scimed Life Systems, Inc. Temporary stent and method of use
US5649978A (en) * 1993-05-11 1997-07-22 Target Therapeutics, Inc. Temporary inflatable intravascular prosthesis
US5562641A (en) * 1993-05-28 1996-10-08 A Bromberg & Co. Ltd. Two way shape memory alloy medical stent
US5441516A (en) * 1994-03-03 1995-08-15 Scimed Lifesystems Inc. Temporary stent
US5445594A (en) * 1994-04-05 1995-08-29 Elist; James J. Implant for expanding penile girth and length
US5882335A (en) * 1994-09-12 1999-03-16 Cordis Corporation Retrievable drug delivery stent
US5902266A (en) * 1994-09-12 1999-05-11 Cordis Corporation Method for delivering a liquid solution to the interior wall surface of a vessel
US5545135A (en) * 1994-10-31 1996-08-13 Boston Scientific Corporation Perfusion balloon stent
US5669931A (en) * 1995-03-30 1997-09-23 Target Therapeutics, Inc. Liquid coils with secondary shape
US5676685A (en) * 1995-06-22 1997-10-14 Razavi; Ali Temporary stent
US5697968A (en) * 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US6579305B1 (en) * 1995-12-07 2003-06-17 Medtronic Ave, Inc. Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material
US6059823A (en) * 1996-02-13 2000-05-09 Scimed Life Systems, Inc. Endovascular apparatus
US6053900A (en) * 1996-02-16 2000-04-25 Brown; Joe E. Apparatus and method for delivering diagnostic and therapeutic agents intravascularly
US6050986A (en) * 1997-12-01 2000-04-18 Scimed Life Systems, Inc. Catheter system for the delivery of a low volume liquid bolus
US6149677A (en) * 1998-03-31 2000-11-21 Innercool Therapies, Inc. Circulating fluid hypothermia method
US20020087209A1 (en) * 1998-09-30 2002-07-04 Edwin Tarun J. Fluid containing endoluminal stent
US6358276B1 (en) * 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6623519B2 (en) * 1998-09-30 2003-09-23 Impra, Inc., Fluid containing endoluminal stent
US20040044394A1 (en) * 1998-09-30 2004-03-04 Edwin Tarun J. Method of recapturing a stent
US6881220B2 (en) * 1998-09-30 2005-04-19 Bard Peripheral Vascular, Inc. Method of recapturing a stent
US6063101A (en) * 1998-11-20 2000-05-16 Precision Vascular Systems, Inc. Stent apparatus and method
US6348067B1 (en) * 1998-11-25 2002-02-19 Israel Aircraft Industries Ltd. Method and system with shape memory heating apparatus for temporarily supporting a tubular organ
US6413273B1 (en) * 1998-11-25 2002-07-02 Israel Aircraft Industries Ltd. Method and system for temporarily supporting a tubular organ
US6258118B1 (en) * 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
US6607551B1 (en) * 1999-05-20 2003-08-19 Scimed Life Systems, Inc. Stent delivery system with nested stabilizer
US6383210B1 (en) * 2000-06-02 2002-05-07 Innercool Therapies, Inc. Method for determining the effective thermal mass of a body or organ using cooling catheter
US20020161427A1 (en) * 2001-04-27 2002-10-31 Dmitry Rabkin Methods for delivering, repositioning and/or retrieving self-expanding stents

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211984A1 (en) * 2003-09-23 2006-09-21 C. R. Bard, Inc. Implant with shape memory
US7524329B2 (en) 2005-02-08 2009-04-28 Wilson-Cook Medical Inc. Self contracting stent
US20060184231A1 (en) * 2005-02-08 2006-08-17 Rucker Brian K Self contracting stent
US8191220B2 (en) 2006-12-04 2012-06-05 Cook Medical Technologies Llc Method for loading a medical device into a delivery system
US20080215131A1 (en) * 2006-12-04 2008-09-04 Cook Incorporated Method for loading a medical device into a delivery system
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US8574262B2 (en) 2007-10-17 2013-11-05 Covidien Lp Revascularization devices
US8070791B2 (en) 2007-10-17 2011-12-06 Mindframe, Inc. Multiple layer embolus removal
US10016211B2 (en) 2007-10-17 2018-07-10 Covidien Lp Expandable tip assembly for thrombus management
US11786254B2 (en) 2007-10-17 2023-10-17 Covidien Lp Methods of managing neurovascular obstructions
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US8197493B2 (en) 2007-10-17 2012-06-12 Mindframe, Inc. Method for providing progressive therapy for thrombus management
US10413310B2 (en) 2007-10-17 2019-09-17 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US8066757B2 (en) 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US10835257B2 (en) 2007-10-17 2020-11-17 Covidien Lp Methods of managing neurovascular obstructions
US9387098B2 (en) 2007-10-17 2016-07-12 Covidien Lp Revascularization devices
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US9320532B2 (en) 2007-10-17 2016-04-26 Covidien Lp Expandable tip assembly for thrombus management
US8945143B2 (en) 2007-10-17 2015-02-03 Covidien Lp Expandable tip assembly for thrombus management
US8945172B2 (en) 2007-10-17 2015-02-03 Covidien Lp Devices for restoring blood flow and clot removal during acute ischemic stroke
US8926680B2 (en) 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US9161766B2 (en) 2008-02-22 2015-10-20 Covidien Lp Methods and apparatus for flow restoration
US11529156B2 (en) 2008-02-22 2022-12-20 Covidien Lp Methods and apparatus for flow restoration
US8940003B2 (en) 2008-02-22 2015-01-27 Covidien Lp Methods and apparatus for flow restoration
US10456151B2 (en) 2008-02-22 2019-10-29 Covidien Lp Methods and apparatus for flow restoration
US8545514B2 (en) 2008-04-11 2013-10-01 Covidien Lp Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
US8888835B2 (en) 2008-04-23 2014-11-18 Cook Medical Technologies Llc Method of loading a medical device into a delivery system
US20110137398A1 (en) * 2008-04-23 2011-06-09 Cook Inc. Method of loading a medical device into a delivery system
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US20100022951A1 (en) * 2008-05-19 2010-01-28 Luce, Forward, Hamilton 7 Scripps, Llp Detachable hub/luer device and processes
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
CN102596279A (en) * 2009-09-20 2012-07-18 麦德托尼克瓦斯科尔勒公司 Method of forming hollow tubular drug eluting medical devices
US20120101560A1 (en) * 2010-10-26 2012-04-26 Kluck Bryan W Retractable flow maintaining stent wire
US20150073526A1 (en) * 2010-10-26 2015-03-12 Bryan W Kluck Retractable Flow Maintaining Stent
US10912933B2 (en) 2014-08-19 2021-02-09 The Regents Of The University Of California Implants for localized drug delivery and methods of use thereof
US11918770B2 (en) 2014-08-19 2024-03-05 The Regents Of The University Of California Implants for localized drug delivery and methods of use thereof
US11324935B2 (en) 2014-08-19 2022-05-10 The Regents Of The University Of California Implants for localized drug delivery and methods of use thereof
WO2018126211A1 (en) * 2016-12-30 2018-07-05 Zoll Circulation, Inc. High efficiency heat exchange catheters for control of patient body temperature
US10758406B2 (en) 2016-12-30 2020-09-01 Zoll Circulation, Inc. High efficiency heat exchange catheters for control of patient body temperature
US11060480B2 (en) 2017-11-14 2021-07-13 The Boeing Company Sound-attenuating heat exchangers and methods of utilizing the same
US11143170B2 (en) * 2019-06-28 2021-10-12 The Boeing Company Shape memory alloy lifting tubes and shape memory alloy actuators including the same
US11525438B2 (en) 2019-06-28 2022-12-13 The Boeing Company Shape memory alloy actuators and thermal management systems including the same
US11168584B2 (en) 2019-06-28 2021-11-09 The Boeing Company Thermal management system using shape memory alloy actuator
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery

Also Published As

Publication number Publication date
JP4295436B2 (en) 2009-07-15
CA2345614A1 (en) 2000-04-06
DE69938516T2 (en) 2009-06-25
US6358276B1 (en) 2002-03-19
DE69938516D1 (en) 2008-05-21
JP2008289921A (en) 2008-12-04
EP1117347A1 (en) 2001-07-25
US6881220B2 (en) 2005-04-19
EP1520556B1 (en) 2008-04-09
US6623519B2 (en) 2003-09-23
EP1520556B9 (en) 2008-11-05
JP4805316B2 (en) 2011-11-02
US20020087209A1 (en) 2002-07-04
US20040044394A1 (en) 2004-03-04
EP1520556A2 (en) 2005-04-06
ES2241325T3 (en) 2005-10-16
EP1520556A3 (en) 2006-08-23
DE69924856T2 (en) 2006-03-02
JP2002525165A (en) 2002-08-13
MXPA01003280A (en) 2002-07-02
DE69924856D1 (en) 2005-05-25
EP1117347B1 (en) 2005-04-20
WO2000018327A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
US6881220B2 (en) Method of recapturing a stent
AU716432B2 (en) Method and apparatus for delivery, deployment and retrieval of a stent comprising shape-memory material
US5993484A (en) Apparatus and method for dilatation of a body lumen and delivery of a prosthesis therein
US6413273B1 (en) Method and system for temporarily supporting a tubular organ
US6258118B1 (en) Removable support device
US7131986B2 (en) Catheter having exchangeable balloon
US7238168B2 (en) Exchangeable catheter
US6348067B1 (en) Method and system with shape memory heating apparatus for temporarily supporting a tubular organ
WO1997040877A1 (en) Focalized intraluminal balloons
JP2008509724A (en) Stent with extrusion coating
JP2008514309A (en) Thin film medical devices and delivery systems
GB2381457A (en) Dilatation catheter system

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION